Fortress Biotech Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights Nov 09, 2018
Checkpoint Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights Nov 02, 2018
Caelum Biosciences Announces Data on CAEL-101 in AL Amyloidosis Selected for Oral Presentations at 60th American Society of Hematology Annual Meeting Nov 02, 2018
Mustang Bio to Present at 8th Annual Partnering Forum at Cell & Gene Meeting on the Mesa Oct 01, 2018
Checkpoint Therapeutics Announces Presentation of Updated Data from Phase 1/2 Trial of EGFR Inhibitor CK-101 Sep 25, 2018
Fortress Biotech Announces Publication of Preclinical Data on AAV-ATP7A Gene Therapy Combined with CUTX-101 (Copper Histidinate) for Menkes Disease in Molecular Therapy: Methods & Clinical Development Sep 12, 2018
